White Matter Diffusion Changes during the First Year of Natalizumab Treatment in Relapsing-Remitting Multiple Sclerosis

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)1030-1037
JournalAmerican Journal of Neuroradiology
Volume37
Issue number6
DOIs
Publication statusPublished - Jun 2016

Cite this

@article{66763eac83184a4bafbc966d8c63b1e9,
title = "White Matter Diffusion Changes during the First Year of Natalizumab Treatment in Relapsing-Remitting Multiple Sclerosis",
author = "Wiebenga, {O. T.} and Schoonheim, {M. M.} and Hulst, {H. E.} and Nagtegaal, {G. J. A.} and Strijbis, {E. M. M.} and Steenwijk, {M. D.} and Polman, {C. H.} and Pouwels, {P. J. W.} and F. Barkhof and Geurts, {J. J. G.}",
year = "2016",
month = "6",
doi = "10.3174/ajnr.A4690",
language = "English",
volume = "37",
pages = "1030--1037",
journal = "American Journal of Neuroradiology",
issn = "0195-6108",
publisher = "American Society of Neuroradiology",
number = "6",

}

TY - JOUR

T1 - White Matter Diffusion Changes during the First Year of Natalizumab Treatment in Relapsing-Remitting Multiple Sclerosis

AU - Wiebenga, O. T.

AU - Schoonheim, M. M.

AU - Hulst, H. E.

AU - Nagtegaal, G. J. A.

AU - Strijbis, E. M. M.

AU - Steenwijk, M. D.

AU - Polman, C. H.

AU - Pouwels, P. J. W.

AU - Barkhof, F.

AU - Geurts, J. J. G.

PY - 2016/6

Y1 - 2016/6

U2 - 10.3174/ajnr.A4690

DO - 10.3174/ajnr.A4690

M3 - Article

VL - 37

SP - 1030

EP - 1037

JO - American Journal of Neuroradiology

JF - American Journal of Neuroradiology

SN - 0195-6108

IS - 6

ER -